These behavioral benefits are underpinned by its marked ability to induce spinogenesis and promote functional synaptogenesis in hippocampal neurons, highlighting its potential as a robust procognitive and antidementia agent [1]
The question is whether his bet will be validated by future trials in healthy, non-obese adults
There is an oral GLP-1 receptor agonist available: semaglutide
Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests Read full article: Weight-loss drugs may lower cancer risk in people with diabetes, a study suggests Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing cancer
Other combination options include metformin for insulin resistance, topiramate for appetite and food cravings, and naltrexone/bupropion for reward-driven eating patterns
Berberine does not activate GLP-1 receptors or other appetite-regulating pathways